Anabolic agents: clinical efficacy versus side effects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000728:Androgens / Q000494:pharmacology; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D002675:Child, Preschool; D004700:Endocrine System Diseases / Q000139:chemically induced; D005032:Ethylestrenol / Q000009:adverse effects; D005260:Female; D005832:Genital Diseases, Male / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007989:Libido / Q000187:drug effects; D008297:Male; D008696:Methandrostenolone / Q000009:adverse effects; D008777:Methyltestosterone / Q000009:adverse effects; D008875:Middle Aged; D009277:Nandrolone / Q000009:adverse effects; D009639:Norethandrolone / Q000009:adverse effects; D010110:Oxymetholone / Q000009:adverse effects; D013197:Stanozolol / Q000009:adverse effects; D013739:Testosterone / Q000009:adverse effects; D014770:Virilism
D045930:Anabolic Agents; D000728:Androgens; D013739:Testosterone; D013197:Stanozolol; D009277:Nandrolone; D005032:Ethylestrenol; D008696:Methandrostenolone; D010110:Oxymetholone; D009639:Norethandrolone; D008777:Methyltestosterone